United States Olanzapine Market Report 2017

Publisher Name :
Date: 24-Feb-2017
No. of pages: 106
Inquire Before Buying

Notes:

Sales, means the sales volume of Olanzapine

Revenue, means the sales value of Olanzapine

This report studies sales (consumption) of Olanzapine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Lilly

- Teva Pharmaceutical

- Dr. Reddy's Laboratories

- Apotex Inc.

- Mylan Pharmaceuticals

- Par Pharmaceutical

- Aurobindo Pharma

- Torrent Pharmaceuticals

- Jubilant Lifesciences

- Sun Pharmaceutical

- Sandoz

- Hansoh Pharmaceutical

- WATSON Pharmaceuticals(Changzhou)

- Zhejiang Langhua Pharmaceuticals

Market Segment by States, covering

- California

- Texas

- New York

- Florida

- Illinois

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Patent Type

- Generics Type

Split by applications, this report focuses on sales, market share and growth rate of Olanzapine in each application, can be divided into

- Olanzapine Tablet

- Other Medicine

United States Olanzapine Market Report 2017

Table of Contents
United States Olanzapine Market Report 2017
1 Olanzapine Overview
1.1 Product Overview and Scope of Olanzapine
1.2 Classification of Olanzapine
1.2.1 Patent Type
1.2.2 Generics Type
1.3 Application of Olanzapine
1.3.1 Olanzapine Tablet
1.3.2 Other Medicine
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Olanzapine (2012-2022)
1.4.1 United States Olanzapine Sales and Growth Rate (2012-2022)
1.4.2 United States Olanzapine Revenue and Growth Rate (2012-2022)
2 United States Olanzapine Competition by Manufacturers
2.1 United States Olanzapine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Olanzapine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Olanzapine Average Price by Manufactures (2015 and 2016)
2.4 Olanzapine Market Competitive Situation and Trends
2.4.1 Olanzapine Market Concentration Rate
2.4.2 Olanzapine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Olanzapine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Olanzapine Sales and Market Share by States (2012-2017)
3.2 United States Olanzapine Revenue and Market Share by States (2012-2017)
3.3 United States Olanzapine Price by States (2012-2017)
4 United States Olanzapine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Olanzapine Sales and Market Share by Type (2012-2017)
4.2 United States Olanzapine Revenue and Market Share by Type (2012-2017)
4.3 United States Olanzapine Price by Type (2012-2017)
4.4 United States Olanzapine Sales Growth Rate by Type (2012-2017)
5 United States Olanzapine Sales (Volume) by Application (2012-2017)
5.1 United States Olanzapine Sales and Market Share by Application (2012-2017)
5.2 United States Olanzapine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Olanzapine Manufacturers Profiles/Analysis
6.1 Lilly
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Olanzapine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Lilly Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Teva Pharmaceutical
6.2.2 Olanzapine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Teva Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Dr. Reddy's Laboratories
6.3.2 Olanzapine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Dr. Reddy's Laboratories Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Apotex Inc.
6.4.2 Olanzapine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Apotex Inc. Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mylan Pharmaceuticals
6.5.2 Olanzapine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Par Pharmaceutical
6.6.2 Olanzapine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Par Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Aurobindo Pharma
6.7.2 Olanzapine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Aurobindo Pharma Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Torrent Pharmaceuticals
6.8.2 Olanzapine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Torrent Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Jubilant Lifesciences
6.9.2 Olanzapine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Jubilant Lifesciences Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Sun Pharmaceutical
6.10.2 Olanzapine Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Sun Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Sandoz
6.12 Hansoh Pharmaceutical
6.13 WATSON Pharmaceuticals(Changzhou)
6.14 Zhejiang Langhua Pharmaceuticals
7 Olanzapine Manufacturing Cost Analysis
7.1 Olanzapine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Olanzapine
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Olanzapine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Olanzapine Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Olanzapine Market Forecast (2017-2022)
11.1 United States Olanzapine Sales, Revenue Forecast (2017-2022)
11.2 United States Olanzapine Sales Forecast by Type (2017-2022)
11.3 United States Olanzapine Sales Forecast by Application (2017-2022)
11.4 Olanzapine Price Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Olanzapine
Table Classification of Olanzapine
Figure United States Sales Market Share of Olanzapine by Type in 2015
Figure Patent Type Picture
Figure Generics Type Picture
Table Application of Olanzapine
Figure United States Sales Market Share of Olanzapine by Application in 2015
Figure Olanzapine Tablet Examples
Figure Other Medicine Examples
Figure United States Olanzapine Sales and Growth Rate (2012-2022)
Figure United States Olanzapine Revenue and Growth Rate (2012-2022)
Table United States Olanzapine Sales of Key Manufacturers (2015 and 2016)
Table United States Olanzapine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Olanzapine Sales Share by Manufacturers
Figure 2016 Olanzapine Sales Share by Manufacturers
Table United States Olanzapine Revenue by Manufacturers (2015 and 2016)
Table United States Olanzapine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Olanzapine Revenue Share by Manufacturers
Table 2016 United States Olanzapine Revenue Share by Manufacturers
Table United States Market Olanzapine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Olanzapine Average Price of Key Manufacturers in 2015
Figure Olanzapine Market Share of Top 3 Manufacturers
Figure Olanzapine Market Share of Top 5 Manufacturers
Table United States Olanzapine Sales by States (2012-2017)
Table United States Olanzapine Sales Share by States (2012-2017)
Figure United States Olanzapine Sales Market Share by States in 2015
Table United States Olanzapine Revenue and Market Share by States (2012-2017)
Table United States Olanzapine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Olanzapine by States (2012-2017)
Table United States Olanzapine Price by States (2012-2017)
Table United States Olanzapine Sales by Type (2012-2017)
Table United States Olanzapine Sales Share by Type (2012-2017)
Figure United States Olanzapine Sales Market Share by Type in 2015
Table United States Olanzapine Revenue and Market Share by Type (2012-2017)
Table United States Olanzapine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Olanzapine by Type (2012-2017)
Table United States Olanzapine Price by Type (2012-2017)
Figure United States Olanzapine Sales Growth Rate by Type (2012-2017)
Table United States Olanzapine Sales by Application (2012-2017)
Table United States Olanzapine Sales Market Share by Application (2012-2017)
Figure United States Olanzapine Sales Market Share by Application in 2015
Table United States Olanzapine Sales Growth Rate by Application (2012-2017)
Figure United States Olanzapine Sales Growth Rate by Application (2012-2017)
Table Lilly Basic Information List
Table Lilly Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lilly Olanzapine Sales Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Olanzapine Sales Market Share (2012-2017)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dr. Reddy's Laboratories Olanzapine Sales Market Share (2012-2017)
Table Apotex Inc. Basic Information List
Table Apotex Inc. Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Apotex Inc. Olanzapine Sales Market Share (2012-2017)
Table Mylan Pharmaceuticals Basic Information List
Table Mylan Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Pharmaceuticals Olanzapine Sales Market Share (2012-2017)
Table Par Pharmaceutical Basic Information List
Table Par Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Par Pharmaceutical Olanzapine Sales Market Share (2012-2017)
Table Aurobindo Pharma Basic Information List
Table Aurobindo Pharma Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aurobindo Pharma Olanzapine Sales Market Share (2012-2017)
Table Torrent Pharmaceuticals Basic Information List
Table Torrent Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Torrent Pharmaceuticals Olanzapine Sales Market Share (2012-2017)
Table Jubilant Lifesciences Basic Information List
Table Jubilant Lifesciences Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Jubilant Lifesciences Olanzapine Sales Market Share (2012-2017)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sun Pharmaceutical Olanzapine Sales Market Share (2012-2017)
Table Sandoz Basic Information List
Table Hansoh Pharmaceutical Basic Information List
Table WATSON Pharmaceuticals(Changzhou) Basic Information List
Table Zhejiang Langhua Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Olanzapine
Figure Manufacturing Process Analysis of Olanzapine
Figure Olanzapine Industrial Chain Analysis
Table Raw Materials Sources of Olanzapine Major Manufacturers in 2015
Table Major Buyers of Olanzapine
Table Distributors/Traders List
Figure United States Olanzapine Production and Growth Rate Forecast (2017-2022)
Figure United States Olanzapine Revenue and Growth Rate Forecast (2017-2022)
Table United States Olanzapine Production Forecast by Type (2017-2022)
Table United States Olanzapine Consumption Forecast by Application (2017-2022)
Table United States Olanzapine Sales Forecast by States (2017-2022)
Table United States Olanzapine Sales Share Forecast by States (2017-2022)
  • Therapies for Resistant and Recurrent Metastatic Cancer
    Published: 06-Nov-2017        Price: US 4950 Onwards        Pages: 338
    The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022. The lung cancer market is expected to grow from $15.7 billion in 2017 to $22.6 billion in 2022 at a CAGR of 7.6% for the period 2017-2022. The stomach cancer segment of the global cancer therapeutics market is expected to grow from $8.2 billion in 2017 to $11.9 billion in 2022 at a CAGR of 7.7% for the period 2017-20......
  • Healthcare Analytics: Technologies and Global Markets
    Published: 31-Oct-2017        Price: US 4950 Onwards        Pages: 105
    The global market for healthcare analytics reached $6.2 billion in 2016. This market should reach nearly $7.2 billion in 2017 and $14.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.8%. The financial analytics market segment is projected to grow from $3.0 billion in 2017 to nearly $5.3 billion in 2020 at a CAGR of 11.9% for the period 2017-2022. The clinical analytics market segment is expected to grow from nearly $2.8 billion in 2017 to $6.2 billion by 2022, incre......
  • Medication Adherence: Systems, Technologies and Global Markets
    Published: 09-Oct-2017        Price: US 4950 Onwards        Pages: 166
    The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021. United States market for medication adherence is expected to grow from $954 million in 2016 to nearly $2.1 billion at a CAGR of 17.5% from 2016 through 2021. Asia market for medication adherence is expected to grow from $225 million in 2016 to $555 million in 2021 at a CAGR of 19.8% from 2016 th......
  • Biologic and Medical Imaging Reagents: Global Markets
    Published: 05-Oct-2017        Price: US 4950 Onwards        Pages: 286
    The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022. The radioactive imaging market will grow from $4.2 billion in 2017 to nearly $8.4 billion by 2022 with a CAGR of 14.7%. The optical imaging market will grow from $4.9 billion in 2017 to around $7.9 billion by 2022 with a CAGR of 9.8%.......
  • Nanotechnology in Medical Applications: The Global Market
    Published: 29-Sep-2017        Price: US 4950 Onwards        Pages: 121
    The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017 through 2022 and should reach $293.1 billion by 2022 from $151.9 billion in 2017. Nanomedicine market for anticancers is projected to grow at a CAGR of 12.3% from 2017 to 2022, and should reach $84.4 billion by 2022 from $47.3 billion in 2017. Nanomedicine market for CNS products is projected to grow at a CAGR of 18.2% and s......
  • Medical Device Security: Technologies and Global Markets
    Published: 27-Sep-2017        Price: US 5500 Onwards        Pages: 140
    The global market for medical device security totaled $4.7 billion in 2016. The market should total $5.2 billion in 2017 and $7.5 billion by 2022, increasing at a compound annual growth rate (CAGR) 7.4% from 2017 to 2022. The hardware segment market for medical device security totaled $2.8 billion in 2016. The market should total over $3.0 billion in 2017 and $4.2 billion by 2022, increasing at a CAGR of 6.7% from 2017 to 2022. The software segment market for medical device securit......
  • Disposable Medical Sensors: Technologies and Global Markets
    Published: 13-Sep-2017        Price: US 4950 Onwards        Pages: 147
    The global market for disposable medical sensors reached $5.1 billion in 2016. The market should reach $5.6 billion in 2017 and $9.0 billion by 2022, at a five-year compound annual growth rate (CAGR) of 10.0% from 2017 to 2022. The North American disposable medical sensors market should reach $2.0 billion in 2017 and $3.1 billion by 2022, at a CAGR of 8.7% from 2017 to 2022. Asia-Pacific market for disposable medical sensors totaled nearly $1.5 billion in 2017 and $2.5 billion by 2......
  • Global and Chinese Dopamine Agonist Industry, 2017 Market Research Report
    Published: 04-Sep-2017        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Dopamine Agonist Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Dopamine Agonist industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dopamine Agonist manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its def......
  • Substance Abuse, Addiction, and Treatment: Global Markets
    Published: 31-Aug-2017        Price: US 3950 Onwards        Pages: 150
    The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%. The drug abuse segment reached nearly $2.3 billion in 2016 and should reach $3.1 billion by 2021, at a CAGR of 6.8%. Nicotine abuse segment reached $758 million in 2016 and should reach nearly $1.1 billion by 2021, at a CAGR of 7.3%. Companies Mentioned Alkermes Plc ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs